Diabetes, Obesity and Metabolism, 24(8), 15531564
Among the side effects of SGLT2 inhibitors, euglycemic diabetic ketoacidosis (EDKA) is one of the most concerning and potentially life-threatening complications
Obesity requires increased public awareness of long-term treatment and management with effective and science-backed approaches
This is particularly relevant for those on GLP-1 medications, as HbA1c allows you to monitor your blood sugar progress alongside your thyroid and iron levels
Illustration PharmaWiki Tgliche Verabreichung (kurzwirksame GLP-1-RA): Exenatid (Byetta, zweimal tglich, ausser Handel) Liraglutid (Saxenda, Victoza, ausser Handel) Lixisenatid (Suliqua, Lyxumia ist ausser Handel) Semaglutid-Tabletten (Rybelsus, oral) Orforglipron (Foundayo, oral)
Early research suggests the GLP-1s could suppress more than just hunger through their impact on brain pathways and hormones